On the contrary, the substances that prevent HSA interaction with Aβ, such as mefenamic acid and risperidone (Table 3), should be considered as potentially harmful with regard to stimulation of amyloid deposition in the brain and AD progression. This evidence concerns the gene ALB and Alzheimer disease.